“We are pleased to see these latest patent issuances that protect PathMaker’s novel technology for the non-invasive treatment of ALS,” said Jake Maslow, J.D., Co-Founder and Chief Intellectual Property Officer at PathMaker. “These patents provide additional protection specific to the treatment of ALS that goes beyond the more than 40 issued patents we already have protecting our platform globally.”

Trinity Biotech notes the additional liquidity will support both the continued development of their innovative continuous glucose monitoring (CGM) technology and the Company’s comprehensive transformation plan.

Mr. Wu Shuang, CEO and chairman of the board of directors of WORK Medical Technology Group, commented, “We are delighted to enter into a strategic partnership with Chartwell Medical. This collaboration reflects our shared commitment to mutual growth and innovation. By leveraging our combined strengths and resources, we aim to enhance operational efficiency, market leadership, and international competitiveness. In addition, our mutual goal is to advance high-end medical technologies, strengthen competitiveness in the global healthcare industry, and accelerate the adoption of cutting-edge solutions in domestic markets.”

“The new ACCESS25 delivery microcatheter has not only proven its tracking capabilities in numerous procedures,” says Dr. Scott McPherson, an interventional neuroradiologist at St. Dominic’s Hospital, “but it has also showcased stability amidst procedural complexities in aneurysm management.”